Sagility Ltd
Incorporated in July 2021, Sagility India Limited (formerly Berkmeer India Pvt. Ltd) provides healthcare-focused technology-enabled solutions and services primarily to U.S.-based clients in the payer and provider segments.[1]
- Market Cap ₹ 20,102 Cr.
- Current Price ₹ 42.9
- High / Low ₹ 57.9 / 35.8
- Stock P/E 21.2
- Book Value ₹ 20.6
- Dividend Yield 0.12 %
- ROCE 13.4 %
- ROE 10.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
Cons
- Company has a low return on equity of 7.58% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 8m | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 923 | 4,218 | 4,754 | 5,570 | 7,193 | |
| 730 | 3,179 | 3,665 | 4,263 | 5,433 | |
| Operating Profit | 193 | 1,039 | 1,088 | 1,307 | 1,760 |
| OPM % | 21% | 25% | 23% | 23% | 24% |
| 18 | 5 | 28 | 47 | 65 | |
| Interest | 65 | 215 | 185 | 127 | 99 |
| Depreciation | 147 | 644 | 689 | 467 | 487 |
| Profit before tax | -2 | 186 | 242 | 760 | 1,239 |
| Tax % | 152% | 23% | 6% | 29% | 25% |
| -5 | 144 | 228 | 539 | 925 | |
| EPS in Rs | -0.02 | 0.75 | 0.53 | 1.15 | 1.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 19% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 86% |
| TTM: | 74% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -9% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1,919 | 1,919 | 4,285 | 4,679 | 4,679 |
| Reserves | 2,108 | 4,288 | 2,158 | 3,657 | 4,980 |
| 4,788 | 2,896 | 2,532 | 1,402 | 1,111 | |
| 1,271 | 1,427 | 1,554 | 1,179 | 1,831 | |
| Total Liabilities | 10,085 | 10,529 | 10,529 | 10,917 | 12,601 |
| 8,621 | 8,607 | 8,667 | 8,997 | 9,356 | |
| CWIP | 5 | 0 | 6 | 0 | 39 |
| Investments | 0 | 0 | 0 | 0 | 336 |
| 1,459 | 1,922 | 1,856 | 1,920 | 2,870 | |
| Total Assets | 10,085 | 10,529 | 10,529 | 10,917 | 12,601 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| -32 | 857 | 973 | 1,214 | 1,203 | |
| -7,711 | -101 | -463 | -958 | -711 | |
| 8,116 | -545 | -751 | -256 | -501 | |
| Net Cash Flow | 374 | 211 | -241 | -0 | -9 |
| Free Cash Flow | -39 | 716 | 791 | 1,092 | 1,011 |
| CFO/OP | -12% | 99% | 101% | 106% | 90% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 366 | 92 | 91 | 83 | 93 |
| Inventory Days | |||||
| Days Payable | |||||
| Cash Conversion Cycle | 366 | 92 | 91 | 83 | 93 |
| Working Capital Days | 58 | 13 | -6 | 25 | 24 |
| ROCE % | 5% | 5% | 10% | 13% |
Insights
In beta| Jul 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Total Number of Employees Count |
|
|||
| Active Client Groups Count |
||||
| Number of Delivery Sites Count |
||||
| Top 10 Client Concentration % |
||||
| Top 5 Client Concentration % |
||||
| Voluntary Attrition Rate (Annualized) % |
||||
| Days Sales Outstanding (DSO) Days |
||||
| Revenue per employee (Annualized) INR Million |
||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
35m - Newspaper publication of audited financial results for the quarter and year ended March 31, 2026
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Investor webinar recording for audited Q4 and FY2026 results, held May 12, 2026, posted on website.
-
Announcement under Regulation 30 (LODR)-Dividend Updates
1d - Board recommended final dividend of Rs.0.10 per share for FY2025-26, subject to AGM approval.
-
Proposal Of ''Employee Stock Options And Performance Stock Units Scheme 2026''
1d - Board approved ESOS 2026 with 3.09 crore options and 12.36 crore PSUs, subject to shareholder approval.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Sagility reported Q4 FY26 revenue of ₹20,243 million and FY26 revenue of ₹71,929 million; final dividend ₹0.10/share.
Concalls
-
May 2026TranscriptAI SummaryPPT
-
May 2026TranscriptAI SummaryPPT
-
Apr 2026Transcript PPT REC
-
Feb 2026Transcript PPT REC
-
Oct 2025TranscriptPPT
-
Oct 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Market Share[1] Headquartered in Bangalore, the company serves only US customers. It holds 1.23% of the U.S. healthcare outsourcing market as of 2023.